Jpmorgan Chase & Co »

Adagio Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Adagio Therapeutics (IVVD) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Adagio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adagio Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adagio Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $52k 13k 3.94
2023-09-30 $35k 21k 1.70
2023-06-30 $3.6k 3.5k 1.05
2023-03-31 $631k 326k 1.94
2022-12-31 $488k 325k 1.50
2022-06-30 $0 353k 0.00
2022-03-31 $1.7M 366k 4.56
2021-12-31 $95k 13k 7.24